INS and type 2 diabetes mellitus: To address these shortcomings and to add novel findings from a contemporary UK setting, we investigated the initiation of prescribing of each of metformin and insulin to adults diagnosed with type 2 diabetes between 2004 and 2022 in Scotland, by SMI status.